OUR SERVICES

Regulatory Affairs, Drug Development, Pharmacovigilance, Medical Writing, Pricing & Reimbursement, Market Access

MORE

ABOUT US

Partner of many pharmaceutical companies, managing hundreds of multi-task projects, on a worldwide-scale

MORE

EVENTS

Discover next events

MORE

BLOG

ALL POSTS
Oct, 16 2020

REGULATORY AFFAIRS – NEW PLATFORM FO...

Starting from October 19th, 2020, developers of human medicines should use the European Medicines Agency (EMA)’s IRIS Regulatory...

READ
Sep, 21 2020

MARKET ACCESS – NEW DRAFT GUIDELINES ON ...

Following the publication of the new Decree relevant to the negotiation of Price and Reimbursement of medicinal products (Decree 2...

READ
Jul, 29 2020

MARKET ACCESS – NEW ITALIAN DECREE ON TH...

After almost a year of waiting, the new Decree from the Italian Ministry of Health and the Ministry of Economy and Finance relevan...

READ
RPN @regulatorypharmanet - JUN 4

CONTACT US

Our experts are available to help you with any question you might have








 
I accept THE PRIVACY POLICY